Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedCore update: new operating-status notice and a new version (v3.2.0) are added, replacing the previous v3.1.0.SummaryDifference2%
- Check19 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedUpdated from Revision: v3.0.1 to v3.0.2 (a minor maintenance version); the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to include a new facility name and location in St. Louis, Missouri, while also adding several medical topics related to cancer and immunology. Notably, some previous content regarding certain cancer types and immunological factors has been removed.SummaryDifference6%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.